Stephen J. Russell, MD, PhD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Stephen J. Russell, MD, PhD

Stephen J. Russell, MD, PhD

Healthcare Professional
Consultant
Division of Hematology
Mayo Clinic
200 First St. SW
Rochester, Minnesota, United States

Dr. Stephen J. Russell is a Hematologist/Internist at Mayo Clinic, Rochester, Minnesota. His areas of interests are multiple myeloma, dysproteinemias, gene therapy, virus therapy, and amyloidosis. He completed his PhD from University of London and fellowship in FRCP from Royal College of Physicians of the United Kingdom.

The research interests of Stephen J. Russell center on demonstrating the value of oncolytic virotherapy as a new modality for the treatment of cancer. Viruses from several families are engineered in Dr. Russell’s laboratory. His team currently has oncolytic projects focusing on measles, vesicular stomatitis virus (VSV), coxsackievirus A21 (CVA21) and Mengo virus. Nonreplicative adeno-associated viruses, lentivirus and adenovirus vectors also are used extensively.

 

Representative Publications:

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio 

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation 

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy 

Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma 

Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma

view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close